Wire · opportunities
Novo Nordisk Taps Anthropic's Claude Science To Speed Up Drug Discovery
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 16 September 2026 · Fusion42 review
Novo Nordisk partners with Anthropic to use AI model Claude Science for speeding up drug discovery and development, aiming to shorten research timelines and improve outcomes amid competition with Eli Lilly. The collaboration focuses on AI-driven solutions for specific R&D workflows in obesity and diabetes drug development.
This Wire brief sits within Fusion42's coverage of Biotech, and 8 sources have reported it between 16 Sep 2026 and 22 Sep 2026.
◆ ◆ The Wire takeaway
You must act now to integrate AI-driven drug discovery tools or risk falling behind companies like Novo Nordisk that are cutting development time with advanced AI. Your R&D workflows will face pressure to adopt AI to keep pace with faster trials and improved candidate selection.
◆ Coverage
8 sources · first reported 16 Sep 2026 · latest 22 Sep 2026
◆ Topics